Chairman of the Board of Directors
Christian Policard is a biophysicist and teacher in the Volvox programme in Israel. He was a founding partner of Biotech Développement Conseils, an international biotech consulting firm that supports innovative companies worldwide. He is currently a senior partner at Global Close Alliance (GCA), a global technology consulting firm operating in over fifty countries. He currently sits on the boards of Vidac Pharma (Israel), RDS (Strasbourg), HTID (Paris) and Technion (Paris-Haifa). He has been Executive Vice President and member of the Global Strategy Committee of Sanofi, Chairman of Cellectis, Director at the Pasteur Institute but also venture capitalist and participated in the creation of numerous companies in France, Israel and the USA.
Larry ABENSUR holds an engineering degree from the Ecole Nationale Supérieure de Chimie de Paris and an MBA from INSEAD. For 9 years, he held various marketing positions in the pharmaceutical industry as Product Manager for Human Biosynthetic Insulin at Eli Lilly, then at UPJOHN France as Marketing Manager. He then became General Manager of PBS Orgenics, an in vitro diagnostics company, for 6 years, until the merger with Self Care (INVERNESS) and the listing on Nasdaq.
In 1993 and 1994, Mr ABENSUR co-founded successively All Diag and Dectra Pharm. In 2005, Larry ABENSUR participated in the creation of Biosynex, which he co-managed until October 2010. Since June 2015, Larry ABENSUR is at the initiative of the creation of the BIOSYNEX group, a leading medtech in rapid diagnostic tests (RDT), where he holds the position of Chairman and CEO.
After a first and second cycle in pharmaceutical studies at the University of Paris V, Thierry PAPER completed an MBA at the Ecole Nationale des Ponts et Chaussées. He also holds a D.E.S. in medical biology from the University of Paris V. Thierry PAPER was an intern in Pharmacy until May 1990. He first joined the Israeli company Orgenics, where he held the positions of project manager and then marketing manager. Between 1993 and 1997, he was in charge of the development of the French company Matara. From 1997 to 2005, he was deputy director of the medical analysis laboratory J-P Accary. He has also been the manager of Axodev, a business development services company for the in vitro diagnostics industry, since 1997.
In 2005, Thierry PAPER took part in the creation of Biosynex, where he is the general and operational manager. In June 2015, he became Managing Director of the BIOSYNEX group.
Jacques AZANCOT is a graduate engineer from the Ecole Centrale de Paris. For more than 30 years, he has held general management positions in high-tech companies specialising in the design and production of special equipment and in the robotisation of industrial processes. For the past five years, he has been running AZALEE Consulting, a company he founded and whose vocation is to assist company managers and private equity funds in their investment or external growth strategy.
As an independent director, Jacques AZANCOT has been a member of the Supervisory Boards or Strategic Committees of diversified SMEs in the food industry, aeronautical subcontracting, building components, medical equipment and industrial tools.